ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 128 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,129,403 | -33.9% | 4,398,453 | 0.0% | 0.59% | -31.1% |
| Q2 2023 | $45,611,958 | +28.2% | 4,398,453 | 0.0% | 0.86% | +6.8% |
| Q1 2023 | $35,583,485 | -48.6% | 4,398,453 | 0.0% | 0.81% | -42.6% |
| Q4 2022 | $69,275,635 | +0.1% | 4,398,453 | 0.0% | 1.40% | -4.9% |
| Q3 2022 | $69,231,000 | +12.7% | 4,398,453 | 0.0% | 1.48% | -9.8% |
| Q2 2022 | $61,403,000 | +95.9% | 4,398,453 | +142.0% | 1.64% | +139.3% |
| Q1 2022 | $31,339,000 | -20.9% | 1,817,808 | +17.5% | 0.68% | -83.3% |
| Q3 2016 | $39,623,000 | -18.4% | 1,547,152 | -41.1% | 4.09% | -39.2% |
| Q2 2016 | $48,534,000 | -2.5% | 2,627,719 | 0.0% | 6.72% | +5.6% |
| Q1 2016 | $49,795,000 | -27.9% | 2,627,719 | +2.5% | 6.36% | -6.9% |
| Q4 2015 | $69,089,000 | – | 2,564,553 | – | 6.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 441,000 | $833,000 | 2.78% |
| MFN Partners Management, LP | 4,000,000 | $7,560,000 | 1.56% |
| Endurant Capital Management LP | 2,055,069 | $3,884,000 | 1.22% |
| Broadfin Capital, LLC | 1,888,039 | $3,568,000 | 0.48% |
| Aisling Capital Management LP | 634,455 | $1,199,000 | 0.46% |
| EcoR1 Capital, LLC | 2,087,312 | $3,945,000 | 0.36% |
| Sofinnova Investments, Inc. | 1,911,573 | $3,613,000 | 0.26% |
| Alambic Investment Management, L.P. | 115,036 | $217,000 | 0.18% |
| Parkman Healthcare Partners LLC | 225,000 | $425,000 | 0.12% |
| Rock Springs Capital Management LP | 1,600,000 | $3,024,000 | 0.10% |